A Comparison of Amethocaine Cream vs. Liposomal Lidocaine Cream for Venipuncture in Children.
Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Jul 14, 2006
Trial Information
Current as of June 10, 2025
Withdrawn
Keywords
ClinConnect Summary
Children commonly require blood taking or placement of an intravenous line for both diagnosis and treatment during their visit to the emergency department. The distress from needle puncture is a particular issue in children. The development of needle phobia can subsequently adversely affect the well-being of the children and their relationship with the medical staff. Thus reduction of pain and distress would be beneficial to patients, parents, and medical personnel.
Amethocaine (tetracaine 4%) (Ametop) is another topical anaesthetic cream which was marketed in Canada over the last 10 years...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All children age who are visiting the paediatric emergency department and need for IV cannulation or blood workup as part of their management. The need for IV placement or blood drawing will be based on the clinical evaluation of the child by experienced triage nursing personnel.
- Exclusion Criteria:
- • Lack of parental agreement
- • Broken skin
- • Known sensitivity to Amethocaine or Liposomal Lidocaine cream.
- • Children with critical illness requiring immediate cannulation (e.g., sepsis, severe dehydration, Trauma)
- • Children who are already receiving opioid analgesia or topical anesthesia.
- • Children who have already participated in the study.
About London Health Sciences Centre Research Institute Or Lawson Research Institute Of St. Joseph's
The London Health Sciences Centre Research Institute, affiliated with Lawson Health Research Institute at St. Joseph's Health Care, is dedicated to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into practical applications, the institute fosters collaboration among leading researchers, clinicians, and healthcare professionals. It aims to improve patient outcomes and enhance the quality of care through rigorous investigation in areas such as cancer, cardiovascular health, and neuroscience. By integrating cutting-edge research with clinical practice, the institute plays a pivotal role in shaping the future of healthcare delivery in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Trial Officials
Michael J Rieder, MD PhD FRCPC
Principal Investigator
Children's Hospital of Western Ontario, University of Western Ontario
Khalid Alawi, MD FRCPC
Study Director
Children's Hospital of Western Ontario
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials